Loading...
Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma
BACKGROUND: Panobinostat is a histone deacetylase inhibitor with antineoplastic and antiangiogenic effects in glioma that may work synergistically with bevacizumab. We conducted a multicenter phase II trial of panobinostat combined with bevacizumab in patients with recurrent high-grade glioma (HGG)....
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4483124/ https://ncbi.nlm.nih.gov/pubmed/25572329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou350 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|